Vanta Bioscience Ltd - 540729 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings, Voting Results and Scrutinizers Report for 5th AGM of the Company held on 31.12.202131-12-2021
Vanta Bioscience Ltd - 540729 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings, Voting Results and Scrutinizers Report for 5th AGM of the Company held on 31.12.2021Vanta Bioscience Ltd - 540729 - 5Th Annual General Meeting On 31.12.2021
5th Annual General Meeting on 31.12.2021Vanta Bioscience Ltd - 540729 - Update In The Matter Of NCLT Application Under Section 9 Of Insolvency And Bankruptcy Code, 2016 - C.P. (IB) - 215/2021 Filed Against The Company
Update In The Matter Of NCLT Application Under Section 9 Of Insolvency And Bankruptcy Code, 2016 - C.P. (IB) - 215/2021 Filed Against The CompanyVanta Bioscience Ltd - 540729 - Expansion Of Scope Of GLP Certification
Expansion of scope of GLP CertificationVanta Bioscience Ltd - 540729 - Unaudited Financial Results For Half Year Ended 30.09.2021
Unaudited Financial results for half year ended 30.09.2021Vanta Bioscience Ltd - 540729 - Board Meeting Intimation for Approval Of The Un-Audited Standalone And Consolidated Financial Statements Of The Company For The Half Year Ended September 30, 2021.
Vanta Bioscience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2021 ,inter alia, to consider and approve the un-audited standalone and consolidated financial statements of the Company for the half year ended September 30, 2021.Vanta Bioscience Ltd - 540729 - Update In The Matter Of NCLT Application Under Section 9 Of Insolvency And Bankruptcy Code, 2016 - C.P. (IB) - 215/2021 Filed Against The Company
Update in the matter of NCLT application under section 9 of Insolvency and Bankruptcy Code, 2016 - C.P. (IB) - 215/2021 filed against the CompanyVanta Bioscience Ltd - 540729 - Shareholding for the Period Ended September 30, 2021
Vanta Bioscience Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2021. For more details, kindly Click hereVanta Bioscience Ltd - 540729 - Statement Of Investor Complaints For The Quarter Ended September 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Zoheb S SayaniDesignation :- Company Secretary and Compliance Officer